116 related articles for article (PubMed ID: 22296166)
1. Room for manoeuvre when prescribing statins to dyslipidaemic patients on antiretroviral therapy.
Myers J; Rayment M; Sonecha S; Moyle G; Boffito M
HIV Med; 2012 Mar; 13(3):190-2. PubMed ID: 22296166
[No Abstract] [Full Text] [Related]
2. Clinical management considerations for dyslipidemia in HIV-infected individuals.
Kirchner JT
Postgrad Med; 2012 Jan; 124(1):31-40. PubMed ID: 22314112
[TBL] [Abstract][Full Text] [Related]
3. Rhabdomyolysis in an HIV-infected patient with impaired renal function concomitantly treated with rosuvastatin and lopinavir/ritonavir.
de Kanter CT; Keuter M; van der Lee MJ; Koopmans PP; Burger DM
Antivir Ther; 2011; 16(3):435-7. PubMed ID: 21555828
[TBL] [Abstract][Full Text] [Related]
4. The role of statins in the setting of HIV infection.
Eckard AR; McComsey GA
Curr HIV/AIDS Rep; 2015 Sep; 12(3):305-12. PubMed ID: 26126687
[TBL] [Abstract][Full Text] [Related]
5. Complications & side effects. Can statins be used as anti-HIV drugs?
TreatmentUpdate; 2004; 16(7):9. PubMed ID: 17219689
[No Abstract] [Full Text] [Related]
6. Statins may not affect CD4 response.
Gadd C
IAPAC Mon; 2006 Feb; 12(2):33. PubMed ID: 17249133
[No Abstract] [Full Text] [Related]
7. Lipid lowering effects of statins and fibrates in the management of HIV dyslipidemias associated with antiretroviral therapy in HIV clinical practice.
Visnegarwala F; Maldonado M; Sajja P; Minihan JL; Rodriguez-Barradas MC; Ong O; Lahart CJ; Hasan MQ; Balasubramanyam A; White AC
J Infect; 2004 Nov; 49(4):283-90. PubMed ID: 15474625
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral and statin drug-drug interactions.
Ray GM
Cardiol Rev; 2009; 17(1):44-7. PubMed ID: 19092370
[TBL] [Abstract][Full Text] [Related]
9. Long-term statin use does not act on the temporal trend of CD4 cell count in patients on virologically effective HAART.
Manfredi R; Calza L; Chiodo F
AIDS; 2006 Feb; 20(3):455-7. PubMed ID: 16439881
[TBL] [Abstract][Full Text] [Related]
10. Statins and natural regulatory T cells in HIV infection.
Mascitelli L; Pezzetta F; Goldstein MR
HIV Med; 2008 Feb; 9(2):131. PubMed ID: 18257776
[No Abstract] [Full Text] [Related]
11. Prolonged statin administration does not act on the cell-mediated immunity of HIV-infected dyslipidemic patients treated with a steady and effective highly active antiretroviral therapy. A two-year prospective study of statin versus fibrate administration.
Manfredi R; Calza L; Chiodo F
J Biol Regul Homeost Agents; 2006; 20(1-2):1-9. PubMed ID: 18088548
[TBL] [Abstract][Full Text] [Related]
12. Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins.
Negredo E; Moltó J; Puig J; Cinquegrana D; Bonjoch A; Pérez-Alvarez N; López-Blázquez R; Blanco A; Clotet B; Rey-Joly C
AIDS; 2006 Nov; 20(17):2159-64. PubMed ID: 17086055
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with incomplete virological response to highly active antiretroviral therapy.
Welch K; Morse A; Clark R; Ogbuokiri T
Clin Infect Dis; 2000 Feb; 30(2):407-8. PubMed ID: 10671360
[No Abstract] [Full Text] [Related]
14. Treating antiretroviral-induced dyslipidemia in HIV-infected adults.
Scordo KA
Nurse Pract; 2010 Jul; 35(7):32-7; quiz 37-8. PubMed ID: 20555242
[No Abstract] [Full Text] [Related]
15. [HAART influences the lipids].
Behrens G
MMW Fortschr Med; 2009 Apr; 151(18):36-8. PubMed ID: 19769073
[No Abstract] [Full Text] [Related]
16. Human Immunodeficiency Virus Infection, Antiretroviral Therapy, and Statin: a Clinical Update.
Zanetti HR; Roever L; Gonçalves A; Resende ES
Curr Atheroscler Rep; 2018 Feb; 20(2):9. PubMed ID: 29423787
[TBL] [Abstract][Full Text] [Related]
17. [HIV-infection: modern antiretroviral therapy].
Rockstroh JK; Spengler U
Dtsch Med Wochenschr; 2004 Sep; 129(37):1921-4. PubMed ID: 15372371
[No Abstract] [Full Text] [Related]
18. Dyslipidaemia, statins and rheumatoid arthritis.
Nurmohamed MT; Dijkmans BA
Ann Rheum Dis; 2009 Apr; 68(4):453-5. PubMed ID: 19286903
[No Abstract] [Full Text] [Related]
19. Statin-fibrate combination therapy.
Feeman WE
Am J Cardiol; 2008 May; 101(10):1521. PubMed ID: 18471475
[No Abstract] [Full Text] [Related]
20. Severe rhabdomyolysis due to rosuvastatin in a liver transplant subject with human immunodeficiency virus and immunosuppressive therapy-related dyslipidemia.
Moreno A; Fortún J; Graus J; Rodriguez-Gandía MA; Quereda C; Pérez-Elías MJ; Nuño J; Wikman P; Moreno S; Bárcena R
Liver Transpl; 2011 Mar; 17(3):331-3. PubMed ID: 21384516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
